Cyclic nucleotide and prostaglandin F2 alpha contents of otosclerotic auditory ossicles
- 17 Downloads
- 1 Citations
Summary
We found that the cyclic-adenosine-3′,5′-rnonophosphate (cAMP) contents of Otosclerotic human ossicles were 40–50 times greater than basal levels. Cyclic-guanosine-3′,5′-monophosphate (cGMP) levels were also found to be greater than in physiological conditions, but lower than in cortical bone. These findings suggest the extensive participation of these nucleotide coenzymes in effector cells during the process of bone resorption. This emphasizes the role of bone-resorbing cells in this process as well as the probable osteoclast progenitor role of vascular endothelial cells and their enhanced activity for differentiation. At the same time, the absence of prostaglandin F2 alpha content in the Otosclerotic bone analyzed appears to exclude cartilage remnants as a source for inducing the changes in remodelling that occur.
Key words
cAMP cGMP Otosclerotic bone remodellingPreview
Unable to display preview. Download preview PDF.
References
- 1.Chevance LG, Bretlau P, Jörgensen MB, Causse J (1970) Otosclerosis. An electron microscopic and cytochemical study. Acta Otolaryngol [Suppl] 272:1–44Google Scholar
- 2.Dietrich JW, Canalis EM, Maina DM, Raisz LG (1976) Hormonal control of bone collagen synthesis in vitro: effects of parathyroid hormone and calcitonin. Endocrinology 98:943–949Google Scholar
- 3.Iyer PV, Gristwood RE (1984) Histopathology of the stapes in otosclerosis. Pathology 16:30–38Google Scholar
- 4.Lindsay JR (1973) Histopathology of otosclerosis. Arch Otolaryngol 97:24–29Google Scholar
- 5.Luben RA, Wong GL, Cohn DV (1976) Biochemical characterization with parathormone and calcitonin of isolated bone cells: provisional identification of osteoclasts and osteoblasts. Endocrinology 99:526–534Google Scholar
- 6.Nager GT (1969) Histopathology of otosclerosis. Arch Otolaryngol 89:341–363Google Scholar
- 7.Parahy C, Linthicum FH Jr (1984) Otosclerosis and otospongiosis: clinical and histological comparisons. Laryngoscope 94:508–512Google Scholar
- 8.Peck WA, Klahr S (1979) Cyclic nucleotides in bone and mineral metabolism. Adv Cyclic Nucleotide Res 11:89–130Google Scholar
- 9.Raisz LG, Canalis EM, Dietrich JW, Kream BE, Gworek SC (1978) Hormonal regulation of bone formation. Recent Prog Horm Res 34:335–355Google Scholar
- 10.Ribári O, Sziklai I (1984) Biochemische Veränderungen in otosklerotischen Gehörknochen und der Perilymphe. In: Majer EH, Zrunek M (eds) Aktuelles in der Otorhinolaryngologie. Georg Thieme, Stuttgart New YorkGoogle Scholar
- 11.Ribári O, Sziklai I, Kiss JG, Sohár I (1983) Cathepsin B activity in otosclerosis. Arch Otorhinolaryngol 238:123–125Google Scholar
- 12.Rodan GA, Bourret LA, Harvey A, Mensi T (1975) Cyclic AMP and cyclic GMP: mediators of the mechanical effects on bone remodelling. Science 189:467–469Google Scholar
- 13.Shambough GE Jr (1967) Surgery of the ear. WB Saunders, Philadelphia, pp 476–480Google Scholar
- 14.Walling MW, Marvaso V, Bernard GW (1978) Stimulation of Guanylate cyclase activity in cultured osteogenic calvarial mesenchymal cells by PTH, calcitonin and insulin. Biochem Biophys Res Commun 83:521–527Google Scholar
- 15.Weintraub S, Wahl LM, Feuerstein N, Winter CC, Reddi AH (1983) Changes in tissue concentration of prostaglandins during endochondral bone differentiation. Biochem Biophys Res Commun 117:746–750Google Scholar
- 16.Wong GL, Kocour BA (1983) Differential sensitivity of osteoclasts and osteoblasts suggests that prostaglandin E1 effects on bone may be mediated primarily through the osteoclasts. Arch Biochem Biophys 224:29–35Google Scholar
- 17.Wright I (1977) Avascular necrosis of bone and its relation to fixation of a small joint: the pathology and etiology of otosclerosis. J Pathol 123:5–25Google Scholar